
GC63906
(R)-BDP9066
Also known as (6R)-8-(3-pyrimidin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-yl)-1,8-diazaspiro[5.5]undecane
(R)-BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK)· (R)-BDP9066 blocks cancer cell invasion· (R)-BDP9066 has the potential for the research of proliferative diseases, such as cancer
ChemicalCAS2284549-25-1MW348.44FormulaC20H24N6
- CAS number
- 2284549-25-1
- Molecular weight
- 348.44
- Formula
- C20H24N6
- InChIKey
- UELSMLDRSQFVHG-HXUWFJFHSA-N
- Catalogue number
- GC63906
- Brand
- GLPBIO
Computed properties PubChem CID 151990000 · XLogP 2.2 · TPSA 69.7 Ų · H-bond donors 2
- XLogP
- 2.2
- TPSA
- 69.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 26
SMILES C1CCN[C@]2(C1)CCCN(C2)C3=C4C(=CNC4=NC=C3)C5=NC=NC=C5
Computed descriptors from PubChem (CID 151990000), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il